BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Holistic medicine
,
Lovastatin
,
rs6983267
,
BRCA1
,
T cell receptor signaling pathway
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ki- antigen
Summary
General Info
Curated Studies
Most Correlated Studies
Thymic stromal cell subsets; age and biomarker comparisons
Explore Curated Studies Results
Literature
Most Relevant Literature
PA28γ, the ring that makes tumors invisible to the immune system?
The 20S proteasome activator PA28γ controls the compaction of chromatin.
Comprehensive analysis of PSME3: from pan-cancer analysis to experimental validation.
circFANCA accelerates the malignant process of OSCC by modulating miR-34a/PA28γ signaling.
HCV infection activates the proteasome via PA28γ acetylation and heptamerization to facilitate the d…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Multigene Risk Score Combined With Ki-67 Dynamic Assessment in Stratified Neoadjuvant Endocrine Ther…
Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patien…
Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Ch…
Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the H…
Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Ant…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ